Impact of chronic periodontitis on levels of glucoregulatory biomarkers in gingival crevicular fluid of adults with and without type 2 diabetes

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Mohamed, Hasaan G ^a,b   Idris, Shaza B ^a   Mustafa, Manal ^c   Ahmed, Mutaz F ^d   Åstrøm, Anne N ^a   Mustafa, Kamal ^a   Ibrahim, Salah O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c Oral Health Competence Center in Western Norway   (Norway)

^d HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; GLUCOSE;

ADULT; AGED; ARTICLE; CHRONIC PERIODONTITIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GINGIVITIS; GLUCOSE METABOLISM; HUMAN; IMMUNOASSAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX BIOMETRIC IMMUNOASSAY; NON INSULIN DEPENDENT DIABETES MELLITUS; COMPLICATION; DEMOGRAPHY; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

ADULT; BIOMARKERS; CHRONIC PERIODONTITIS; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; GINGIVAL CREVICULAR FLUID; GLUCOSE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 84930614904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127660     Document Type: Article

References (51)

1. Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007; 44: 127-153. PMID: 17474930
2. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC public health. 2011; 11:564. doi: 10.1186/1471-2458-11-564 PMID: 21756350
3. IDF Diabetes Atlas update poster, 6th edn. Brussels, Belgium. International Diabetes Federation. 2014.
4. Lamster IB, Lalla E, Borgnakke WS, Taylor GW. The relationship between oral health and diabetes mellitus. J Am Dent Assoc 2008 Oct; 139(10 Suppl): 19S-24S.
5. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet. 2005; 366(9499): 1809-1820. PMID: 16298220
6. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000. 2004; 34:9-21. PMID: 14717852
7. Hanes PJ, Krishna R. Characteristics of inflammation common to both diabetes and periodontitis: are predictive diagnosis and targeted preventive measures possible? The EPMA journal. 2010 Mar; 1(1): 101-116. doi: 10.1007/s13167-010-0016-3 PMID: 23199045
8. Hujoel PP, White BA, Garcia RI, Listgarten MA. The dentogingival epithelial surface area revisited. J Periodontal Res. 2001 Feb; 36(1):48-55. PMID: 11246704
9. Sima C, Glogauer M. Diabetes mellitus and periodontal diseases. Current diabetes reports. 2013 Jun; 13(3): 445-452. doi: 10.1007/s11892-013-0367-y PMID: 23430581
10. Demmer RT, Jacobs DR, Desvarieux M. Periodontal disease and incident type 2 diabetes results from the first national health and nutrition examination survey and its epidemiologic follow-up study. Diabetes care. 2008; 31(7): 1373-1379. doi: 10.2337/dc08-0026 PMID: 18390797
11. Ide R, Hoshuyama T, Wilson D, Takahashi K, Higashi T. Periodontal disease and incident diabetes a seven-year study. Journal of dental research. 2011; 90(1): 41-46. doi: 10.1177/0022034510381902 PMID: 21041549
12. Lamster IB, Ahlo JK. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Annals of the New York Academy of Sciences. 2007 Mar; 1098: 216-229. PMID: 17435131
13. Ohta K, Laborde NJ, Kajiya M, Shin J, Zhu T, Thondukolam AK, et al. Expression and possible immune-regulatory function of ghrelin in oral epithelium. Journal of dental research. 2011 Nov; 90(11): 1286-1292. doi: 10.1177/0022034511420431 PMID: 21865591
14. Karthikeyan BV, Pradeep AR. Leptin levels in gingival crevicular fluid in periodontal health and disease. J Periodontal Res. 2007 Aug; 42(4): 300-304. PMID: 17559625
15. Pradeep AR, Raghavendra NM, Prasad MV, Kathariya R, Patel SP, Sharma A. Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. J Periodontol. 2011 Sep; 82(9): 1314-1319. doi: 10.1902/jop.2011.100690 PMID: 21309715
16. Mohamed HG, Idris SB, Ahmed MF, Bøe OE, Mustafa K, Ibrahim SO, et al. Association between Oral Health Status and Type 2 Diabetes Mellitus among Sudanese Adults: A Matched Case-Control Study. PloS ONE. 2013; 8(12): e82158. doi: 10.1371/journal.pone.0082158 PMID: 24349205
17. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008 Jan; 31 Suppl 1: S55-60. doi: 10.2337/dc08-S055 PMID: 18165338
18. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta odontologica Scandinavica. 1964 Feb; 22: 121-135. PMID: 14158464
19. Katagiri S, Nagasawa T, Kobayashi H, Takamatsu H, Bharti P, Izumiyama H, et al. Improvement of glycemic control after periodontal treatment by resolving gingival inflammation in type 2 diabetic patients with periodontal disease. Journal of diabetes investigation. 2012 Aug 20; 3(4): 402-409. doi: 10.1111/j.2040-1124.2012.00209.x PMID: 24843597
20. Eke PI, Page RC, Wei L, Thornton-Evans G, Genco RJ. Update of the case definitions for population-based surveillance of periodontitis. J Periodontol. 2012 Dec; 83(12): 1449-1454. doi: 10.1902/jop.2012.110664 PMID: 22420873
21. Zhong Y, Slade GD, Beck JD, Offenbacher S. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. Journal of clinical periodontology. 2007 Apr; 34(4): 285-293. PMID: 17378884
22. Lopez R, Dahlen G, Baelum V. Subgingival microbial consortia and the clinical features of periodontitis in adolescents. European journal of oral sciences. 2011 Dec; 119(6): 455-462. doi: 10.1111/j.1600-0722.2011.00875.x PMID: 22112031
23. Houser B. Bio-Rad's Bio-Plex(R) suspension array system, xMAP technology overview. Archives of physiology and biochemistry. 2012 Oct; 118(4): 192-196. doi: 10.3109/13813455.2012.705301 PMID: 22852821
24. Thunell DH, Tymkiw KD, Johnson GK, Joly S, Burnell KK, Cavanaugh JE, et al. A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res. 2010 Feb; 45(1): 148-152. doi: 10.1111/j.1600-0765.2009.01204.x PMID: 19602112
25. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001 Dec; 6(1):99-112. PMID: 11887478
26. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nature reviews Endocrinology. 2011 Dec; 7(12):738-748. doi: 10.1038/nrendo.2011.106 PMID: 21709707
27. Liu MY, Xydakis AM, Hoogeveen RC, Jones PH, Smith EO, Nelson KW, et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clinical chemistry. 2005 Jul; 51(7): 1102-1109. PMID: 15976097
28. Georgiou HM, Lappas M, Georgiou GM, Marita A, Bryant VJ, Hiscock R, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta diabetologica. 2008 Sep; 45(3): 157-165. doi: 10.1007/s00592-008-0037-8 PMID: 18496643
29. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. The journals of gerontology Series A, Biological sciences and medical sciences. 2008 Aug; 63(8): 879-884. PMID: 18772478
30. Almaghlouth AA, Cionca N, Cancela JA, Décaillet F, Courvoisier DS, Giannopoulou C, et al. Effect of periodontal treatment on peak serum levels of inflammatory markers. Clinical oral investigations. 2014: 1-9. doi: 10.1007/s00784-014-1333-z PMID: 25366871
31. Hoekstra JB, van Rijn HJ, Erkelens DW, Thijssen JH. C-peptide. Diabetes Care. 1982 Jul-Aug; 5(4): 438-446. PMID: 6759081
32. Chowta MN, Adhikari PM, Chowta NK, Shenoy AK, D'Souza S. Serum C peptide level and renal function in diabetes mellitus. Indian journal of nephrology. 2010 Jan; 20(1): 25-28. doi: 10.4103/0971-4065.62093 PMID: 20535267
33. Merchant AT, Jethwani M, Choi YH, Morrato EH, Liese AD, Mayer-Davis E. Associations between periodontal disease and selected risk factors of early complications among youth with type 1 and type 2 diabetes: a pilot study. Pediatric diabetes. 2011 Sep; 12(6): 529-535. doi: 10.1111/j.1399-5448.2010.00736.x PMID: 21392193
34. Alssema M, Rijkelijkhuizen JM, Holst JJ, Teerlink T, Scheffer PG, Eekhoff EM, et al. Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT. European journal of endocrinology / European Federation of Endocrine Societies. 2013 Oct; 169(4): 421-430. doi: 10.1530/EJE-13-0487 PMID: 23864340
35. Calanna S, Christensen M, Holst JJ, Laferrere B, Gluud LL, Vilsboll T, et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia. 2013 May; 56(5): 965-972. doi: 10.1007/s00125-013-2841-0 PMID: 23377698
36. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocrine reviews. 2007 Feb; 28(1): 84-116. PMID: 17261637
37. D'Alessio D. The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes, obesity & metabolism. 2011 Oct; 13 Suppl 1: 126-132.
38. Pulkkinen L, Ukkola O, Kolehmainen M, Uusitupa M. Ghrelin in diabetes and metabolic syndrome. International journal of peptides. 2010.
39. Yilmaz G, Kirzioglu FY, Doguc DK, Kocak H, Orhan H. Ghrelin levels in chronic periodontitis patients. Odontology / the Society of the Nippon Dental University. 2014 Jan; 102(1): 59-67. doi: 10.1007/s10266-012-0100-3 PMID: 23292319
40. Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resistin, and ghrelin-implications for inflammatory bowel disease. Molecular nutrition & food research. 2008 Aug; 52(8): 855-866.
41. Coppari R, Bjorbaek C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nature reviews Drug discovery. 2012 Sep; 11(9): 692-708. doi: 10.1038/nrd3757 PMID: 22935803
42. Tatti P, Masselli L, Buonanno A, Di Mauro P, Strollo F. Leptin levels in diabetic and nondiabetic subjects. Endocrine. 2001 Aug; 15(3): 305-308. PMID: 11762704
43. Ahmed AM. Evaluation of plasma leptin levels in Sudanese diabetic patients. Egypt Acad J Biolog Sci 2012; 4(1): 107-112.
44. Johnson RB, Serio FG. Leptin within healthy and diseased human gingiva. J Periodontol. 2001 Sep; 72(9): 1254-1257. PMID: 11577959
45. Kang SM, Kwon HM, Hong BK, Kim D, Kim IJ, Choi EY, et al. Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. Yonsei medical journal. 2000 Feb; 41(1): 68-75. PMID: 10731922
46. Lyon CJ, Hsueh WA. Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease. The American journal of medicine. 2003 Dec 8; 115 Suppl 8A:62S-68S. PMID: 14678868
47. Schneider DJ, Sobel BE. PAI-1 and diabetes: a journey from the bench to the bedside. Diabetes Care. 2012 Oct; 35(10): 1961-1967. PMID: 22996180
48. Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, et al. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism: clinical and experimental. 1986 Mar; 35(3): 250-253. PMID: 3081778
49. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science (New York, NY). 2005 Jan 21; 307(5708): 426-430. PMID: 15604363
50. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. Journal of immunology. 2007 Feb 1; 178(3): 1748-1758. PMID: 17237424
51. Petropoulos G, McKay IJ, Hughes FJ. The association between neutrophil numbers and interleukin-1alpha concentrations in gingival crevicular fluid of smokers and non-smokers with periodontal disease. Journal of clinical periodontology. 2004 May; 31(5): 390-395. PMID: 15086622